Vivani Medical, Inc. VANI
Biotechnology: Electromedical & Electrotherapeutic Apparatus · IPO 2014 · data as of November 13, 2026
Vivani Medical, Inc. (VANI) is a healthcare company listed in the US with a market value of about $91M.
Its overall Stock Analiz score is 0.0 out of 5 (weak). The strongest part is value (0/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -90%.
About Vivani Medical
Vivani Medical is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus, IPO year 2014. Revenue went from $3M in 2014 to $3M in 2019, a decline of about 0.1% a year. It was profitable in 0 of the last 10 years in our data.
Score: 0.0 / 5
Checks passed
- —
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — | — | $3M | $7M | $8M | $4M |
| Net income | -$27M | -$23M | -$26M | -$14M | -$13M | -$15M | -$34M | -$35M | -$29M | -$33M |
| Free cash flow | -$25M | -$21M | -$25M | -$19M | -$12M | -$17M | -$28M | -$30M | -$24M | -$26M |
| EPS (diluted) | $-0.43 | $-0.43 | $-0.00 | — | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.01 |
| Net margin | — | — | — | — | — | — | -994.1% | -508.9% | -358.1% | -829.5% |
| ROIC | -62.9% | -52.8% | -51.4% | -37.1% | -246.1% | -283.6% | -271.6% | -472.3% | -286.7% | -235.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 3 analysts is $3.83, 280% above the current price; targets range from $3.50 to $4.00; the consensus rating is “Strong buy”; expected EPS is $-0.32 for the fiscal year ending December 31, 2026.
Frequently asked questions
Does Vivani Medical pay a dividend?
Not currently.
Is Vivani Medical a good stock to buy?
We do not give buy or sell advice. Vivani Medical scores 0.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.